Get Half Baycd: The Future of Web3 Cannabis
Arizona, Aug 31, 2022 – (ACN Newswire) – One of the greatest hurdles in the…
Arizona, Aug 31, 2022 – (ACN Newswire) – One of the greatest hurdles in the…
Integration will help finance professionals understand their data and make critical business decisions RALEIGH, N.C.–(BUSINESS…
SP-103 receives Fast Track Designation, which makes it eligible for some or all of the…
SINGAPORE, Aug 31, 2022 – (ACN Newswire) – Apeiron Bioenergy has successfully closed an equity…
The global semiconductor revenue is expected to reach $661 billion in 2022, up by 13.7%…
Includes offers for securities issued by United States Steel Corporation and co-issued by Big River…
At June 30, 2022, cash-on-hand was US$60.4 million with pro-forma US$105.5 million after raising gross…
HONG KONG, Aug 31, 2022 – (ACN Newswire) – China’s major furniture product manufacturer Huisen…
HONG KONG, Aug 31, 2022 – (ACN Newswire) – ESPRIT HOLDINGS LIMITED (the “Company”, together…
GTB-3650’s IND application with the FDA expected by end of first quarter of 2023 BRISBANE,…
– Topline data for anti-CTLA-4 antibody, ADG116, shows compelling clinical safety and complete and partial…
MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…
NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
WOODCLIFF LAKE, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL),…
FREMONT, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
SAN FRANCISCO and SAN DIEGO, Aug. 30, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
BRIDGEWATER, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
TUSTIN, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics…